The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Depression Doubled Stroke Risk In Study Of Middle-Aged Women
Middle-aged women who have depression are almost twice as likely to have a stroke as women the same age who are not depressed, says a new study.
Is The Asian Space Science Drive Harming Development?
Are the large sums of money invested into building prestigious space programs diverting funding from key areas such as health and education?
India Develops First Indigenous Rotavirus Vaccine
The Government of India and Bharat Biotech have announced positive Phase III results from India's first indigenous, low-priced rotavirus vaccine.
All-Girl Trio From Temasek Polytechnic Wins IES Design Awards 2013
An all-girl group from Temasek Polytechnic in Singapore has won the Gold Award at the IES Design Awards 2013 for its bipod walking frame design.
Researchers Carry Out Large-Scale Study Of Salt Consumption In India
Researchers are carrying out a large-scale study of the salt intake of Indian adults towards the development of a national salt reduction strategy.
Prostate Cancer Foundation Awards Two Young Chinese Investigators
The Prostate Cancer Foundation has funded two new young Chinese investigators to lead innovative prostate cancer research projects within the country.
NTU Start-Up Builds Remote-Operated Water Treatment Plant In Vietnam
An NTU start-up, De.Mem Pte Ltd, successfully launched its first overseas water treatment plant in Vietnam this month.
RuiYi, Genor Biopharma To Collaborate On Anti-Inflammation Monoclonal Drug
RuiYi Inc. has entered into an exclusive license and collaborative agreement with Genor Biopharma for the development of RYI-008 in China.
SciClone Licenses Chronic Heart Failure Drug From Zensun
SciClone Pharma has licensed from Zensun (Shanghai) Science & Technology Co. Ltd. its chronic heart failure drug, Neucardin.